Speedway, IN, United States of America

Tammy Joy Sajdyk

This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tammy Joy Sajdyk. Retrieved from https://idiyas.com/inventor/tammy-joy-sajdyk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tammy Joy Sajdyk: Innovator in Pharmaceutical Chemistry

Introduction

Tammy Joy Sajdyk is a notable inventor based in Speedway, Indiana. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds.

Latest Patents

Tammy holds a patent for 5-HT1F antagonists, which provides a novel class of compounds represented by Formula I. This invention has potential applications in treating various medical conditions, showcasing her expertise in drug development.

Career Highlights

Tammy is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. Her work focuses on advancing therapeutic solutions that can improve patient outcomes.

Collaborations

Throughout her career, Tammy has collaborated with esteemed colleagues, including Lee A. Phebus and Vincent Patrick Rocco. These partnerships have enhanced her research and contributed to the success of her projects.

Conclusion

Tammy Joy Sajdyk is a pioneering inventor whose work in pharmaceutical chemistry continues to impact the industry positively. Her dedication to innovation and collaboration exemplifies the spirit of scientific advancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…